How to Help Your Patients Find Anoro Ellipta (Umeclidinium/Vilanterol) In Stock: A Provider's Guide

In clinical practice, the question of medication availability is increasingly as important as the prescription itself. For patients with COPD who depend on Anoro Ellipta (umeclidinium/vilanterol) as their daily maintenance inhaler, inconsistent pharmacy stocking creates a significant care gap — and often generates a call to your office.

This guide gives you and your care team a practical toolkit for helping patients find Anoro Ellipta, navigate insurance, and maintain COPD control when access becomes a barrier.

Step 1: Write the Prescription in a Way That Maximizes Fill Success

A prescribing-level change can immediately expand pharmacy options for your patients. Consider the following:

• Prescribe by generic name: Write "umeclidinium/vilanterol 62.5/25 mcg inhalation powder" instead of "Anoro Ellipta." This allows pharmacists to dispense either the brand or the Prasco authorized generic, doubling available inventory sources without any change in treatment.
• Prescribe a 90-day supply: A 90-day prescription reduces the frequency of fill attempts and takes advantage of mail-order pharmacy options through Medicare Part D and commercial plans. Many COPD patients benefit from mail order since the drug is delivered directly to their home.
• Add "substitution permitted" notation: Explicit notation on the prescription confirming generic substitution is acceptable can help pharmacists and patients avoid confusion about whether the generic is appropriate.

Step 2: Direct Patients to Pharmacies That Reliably Stock Specialty Inhalers

Not all pharmacies are equal when it comes to specialty inhalers. Share these recommendations with your patients or care coordinators:

• Independent pharmacies: Often stock a broader range of respiratory medications and have more flexibility to place special orders quickly.
• Hospital outpatient pharmacies: Affiliated with health systems, these pharmacies reliably stock respiratory medications and may be preferred by your hospital-based COPD patients.
• Mail-order pharmacies: Eliminate the local stocking problem entirely. Especially valuable for patients with limited mobility, those in rural areas, or anyone who has difficulty getting to a pharmacy.

Step 3: Use medfinder to Help Patients Locate the Medication

One of the most efficient tools available for addressing medication access is medfinder. This service calls pharmacies near the patient's location to find which ones have the medication in stock — and sends results by text. For elderly COPD patients with limited mobility or those who struggle to make multiple phone calls, this removes a significant real-world barrier.

Your office staff can help initiate a medfinder search on behalf of patients during medication-related calls, or provide patients with the website address to use at home.

Step 4: Navigate Prior Authorization Efficiently

Prior authorization (PA) is a common barrier for Anoro Ellipta, particularly on Medicare Part D plans that now prefer the authorized generic. To improve PA approval rates:

• Include GOLD staging, FEV1/FVC results, and mMRC or CAT score in the clinical summary
• Document exacerbation history (hospitalizations, ED visits, steroid courses) in the past 12 months
• Reference GOLD 2024 recommendations for dual LAMA/LABA in symptomatic patients uncontrolled on monotherapy
• If step therapy requires documenting LAMA monotherapy failure, ensure tiotropium trial documentation is in the chart

39,453+ patients found their medications in stock

39K+

Find Umeclidinium/Vilanterol In Stock Today →

Step 5: Know the Patient Assistance Options

For uninsured or underinsured patients who cannot afford Anoro Ellipta:

• GSK For You Patient Assistance Program: Provides Anoro Ellipta at no cost to eligible uninsured or income-qualifying patients. Patients can apply at gskpaf.org or call 888-825-5249. Your office can also assist by submitting the prescription.
• GoodRx and discount cards: For uninsured patients who need the medication immediately, GoodRx and similar discount cards can reduce the cash price of Anoro Ellipta from ~$500 to approximately $270-$340 per inhaler.
• Office samples: GSK representatives may provide sample inhalers to your office. These can bridge patients while PA requests are processed or assistance programs are applied for.

Step 6: Document and Communicate the Access Issue

When a patient experiences persistent difficulty filling Anoro Ellipta, document this in the medical record. This documentation:

• Strengthens PA appeals and exception requests
• Provides context for any interim exacerbation that may occur
• Helps identify patterns if multiple patients in your panel are affected by the same stocking issue

Skip the calls, skip the stress.

Find Umeclidinium/Vilanterol In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Summary Checklist for Your Practice

• Prescribe by generic name to allow brand or Prasco generic to fill
• Recommend 90-day supply and mail-order for qualifying patients
• Direct patients to medfinder for multi-pharmacy availability search
• Refer eligible uninsured patients to GSK For You PAP (888-825-5249)
• Maintain a bridging alternative prescription (e.g., Stiolto Respimat) ready if patient cannot access Anoro for an extended period